Lidocaine HCI 2% and Epinephrine 1:100 recall
FDA recall D-0229-2026 · initiated Oct 31, 2025
Novocol Pharmaceutical of Canada, Inc. recalled Lidocaine HCI 2% and Epinephrine 1:100 in Oct 2025 — an FDA Class II recall (D-0229-2026) because Defective container: cracked/broken cartridges.
May cause temporary or medically reversible harm; low probability of serious harm.
Why it was recalled
Defective container: cracked/broken cartridges
Labelling, packaging or a product mix-up
The wrong information — or the wrong medicine — ended up in the pack. A mix-up is a manufacturing failure that can still be dangerous to swallow.
This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.
Is your product affected? Check the lot number
A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.
Quantity recalled: 12,033 cartons
Details
- Product
- Lidocaine HCI 2% and Epinephrine 1:100,000 (Lidocaine HCI and Epinephrine Injection USP), packaged in a carton containing 50 single-dose Cartridges, 1.7 ml each, Rx only, Manufactured for Patterson Dental Supply, Inc., 1031 Mendota Heights Road, Saint Paul, MN55120, Manufactured by: Novocol Pharmaceutical of Canada, Inc., NDC 50227-1030-5.
- Recalling company
- Novocol Pharmaceutical of Canada, Inc.
- Classification
- Class II
- Status
- Ongoing
- Type
- Voluntary: Firm initiated
- Distribution
- U.S.A. Nationwide
- Initiated
- Oct 31, 2025
- FDA report date
- Dec 24, 2025
Frequently asked
- Was Lidocaine HCI 2% and Epinephrine 1:100 recalled?
- Novocol Pharmaceutical of Canada, Inc. recalled Lidocaine HCI 2% and Epinephrine 1:100 in Oct 2025 — an FDA Class II recall (D-0229-2026) because Defective container: cracked/broken cartridges. May cause temporary or medically reversible harm; low probability of serious harm.
- Why was Lidocaine HCI 2% and Epinephrine 1:100 recalled?
- Per the FDA enforcement record, the reason for recall D-0229-2026 was: Defective container: cracked/broken cartridges
- Is a recalled Lidocaine HCI 2% and Epinephrine 1:100 dangerous to take?
- An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
- Which lots of Lidocaine HCI 2% and Epinephrine 1:100 are affected?
- Distributed: U.S.A. Nationwide. The recall covers these lots — Lot: D05362A, expires: 07-31-2027. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0229-2026.